156 related articles for article (PubMed ID: 31382118)
1. Synthesis, biological evaluation, and docking studies of new raloxifene sulfonate or sulfamate derivatives as inhibitors of nucleotide pyrophosphatase/phosphodiesterase.
El-Gamal MI; Ullah S; Zaraei SO; Jalil S; Zaib S; Zaher DM; Omar HA; Anbar HS; Pelletier J; Sévigny J; Iqbal J
Eur J Med Chem; 2019 Nov; 181():111560. PubMed ID: 31382118
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of sulfonate and sulfamate derivatives possessing benzofuran or benzothiophene nucleus as inhibitors of nucleotide pyrophosphatases/phosphodiesterases and anticancer agents.
Anbar HS; El-Gamal R; Ullah S; Zaraei SO; Al-Rashida M; Zaib S; Pelletier J; Sévigny J; Iqbal J; El-Gamal MI
Bioorg Chem; 2020 Nov; 104():104305. PubMed ID: 33017718
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, biological evaluation, and docking studies of novel pyrrolo[2,3-b]pyridine derivatives as both ectonucleotide pyrophosphatase/phosphodiesterase inhibitors and antiproliferative agents.
Ullah S; El-Gamal MI; El-Gamal R; Pelletier J; Sévigny J; Shehata MK; Anbar HS; Iqbal J
Eur J Med Chem; 2021 May; 217():113339. PubMed ID: 33744686
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of biphenyl oxazole derivatives via Suzuki coupling and biological evaluations as nucleotide pyrophosphatase/phosphodiesterase-1 and -3 inhibitors.
Ahmad H; Ullah S; Rahman F; Saeed A; Pelletier J; Sévigny J; Hassan A; Iqbal J
Eur J Med Chem; 2020 Dec; 208():112759. PubMed ID: 32883636
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, biological evaluation, and docking studies of new pyrazole-based thiourea and sulfonamide derivatives as inhibitors of nucleotide pyrophosphatase/phosphodiesterase.
Ullah S; El-Gamal MI; Zaib S; Anbar HS; Zaraei SO; Sbenati RM; Pelletier J; Sévigny J; Oh CH; Iqbal J
Bioorg Chem; 2020 Jun; 99():103783. PubMed ID: 32224334
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, biological evaluation, and molecular docking study of sulfonate derivatives as nucleotide pyrophosphatase/phosphodiesterase (NPP) inhibitors.
Semreen MH; El-Gamal MI; Ullah S; Jalil S; Zaib S; Anbar HS; Lecka J; Sévigny J; Iqbal J
Bioorg Med Chem; 2019 Jul; 27(13):2741-2752. PubMed ID: 31088715
[TBL] [Abstract][Full Text] [Related]
7. Probing the high potency of pyrazolyl pyrimidinetriones and thioxopyrimidinediones as selective and efficient non-nucleotide inhibitors of recombinant human ectonucleotidases.
Andleeb H; Hameed S; Ejaz SA; Khan I; Zaib S; Lecka J; Sévigny J; Iqbal J
Bioorg Chem; 2019 Jul; 88():102893. PubMed ID: 30986550
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, in vitro, and in silico studies of morpholine-based thiosemicarbazones as ectonucleotide pyrophosphatase/phosphodiesterase-1 and -3 inhibitors.
Tasleem M; Pelletier J; Sévigny J; Hussain Z; Khan A; Al-Harrasi A; El-Kott AF; Taslimi P; Negm S; Shafiq Z; Iqbal J
Int J Biol Macromol; 2024 May; 266(Pt 2):131068. PubMed ID: 38531526
[TBL] [Abstract][Full Text] [Related]
9. Highly potent and selective ectonucleotide pyrophosphatase/phosphodiesterase I inhibitors based on an adenosine 5'-(α or γ)-thio-(α,β- or β,γ)-methylenetriphosphate scaffold.
Nadel Y; Lecka J; Gilad Y; Ben-David G; Förster D; Reiser G; Kenigsberg S; Camden J; Weisman GA; Senderowitz H; Sévigny J; Fischer B
J Med Chem; 2014 Jun; 57(11):4677-91. PubMed ID: 24846781
[TBL] [Abstract][Full Text] [Related]
10. Highly Selective and Potent Ectonucleotide Pyrophosphatase-1 (NPP1) Inhibitors Based on Uridine 5'-P
Zelikman V; Pelletier J; Simhaev L; Sela A; Gendron FP; Arguin G; Senderowitz H; Sévigny J; Fischer B
J Med Chem; 2018 May; 61(9):3939-3951. PubMed ID: 29681152
[TBL] [Abstract][Full Text] [Related]
11. Nonhydrolyzable ATP analogues as selective inhibitors of human NPP1: a combined computational/experimental study.
Lecka J; Ben-David G; Simhaev L; Eliahu S; Oscar J; Luyindula P; Pelletier J; Fischer B; Senderowitz H; Sévigny J
J Med Chem; 2013 Nov; 56(21):8308-20. PubMed ID: 24083941
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of novel quinazoline-4-piperidinesulfamide derivatives as inhibitors of NPP1.
Forcellini E; Boutin S; Lefebvre CA; Shayhidin EE; Boulanger MC; Rhéaume G; Barbeau X; Lagüe P; Mathieu P; Paquin JF
Eur J Med Chem; 2018 Mar; 147():130-149. PubMed ID: 29427906
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, in vitro antiproliferative activity, and in silico studies of fused tricyclic coumarin sulfonate derivatives.
El-Gamal MI; Oh CH
Eur J Med Chem; 2014 Sep; 84():68-76. PubMed ID: 25016229
[TBL] [Abstract][Full Text] [Related]
14. Antiproliferative activity of cycloalkanecarboxamide derivatives possessing sulfonate or sulfamate moiety.
El-Gamal MI; Omar HA; Semreen MH; Younes IA; Zaghloul YY; Abbas AE; Moussa IG; Hersi F; Oh CH
Bioorg Chem; 2020 Apr; 97():103677. PubMed ID: 32120075
[TBL] [Abstract][Full Text] [Related]
15. Design, Synthesis, and Preliminary Bioactivity Evaluation of 2,7-Substituted Carbazole Derivatives as Potent Autotaxin Inhibitors and Antitumor Agents†.
Wang W; Zhao F; Zhao Y; Pan W; Cao P; Wu L; Wang Z; Zhao X; Zhao Y; Wang H
Anticancer Agents Med Chem; 2019; 19(2):256-264. PubMed ID: 30173652
[TBL] [Abstract][Full Text] [Related]
16. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F
Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967
[TBL] [Abstract][Full Text] [Related]
17. Novel anti-Acanthamoebic properties of raloxifene sulfonate/sulfamate derivatives.
Siddiqui R; El-Gamal MI; Sajeev S; Zaraei SO; Khan NA
Mol Biochem Parasitol; 2023 Dec; 256():111582. PubMed ID: 37562558
[TBL] [Abstract][Full Text] [Related]
18. Exploration of carboxy pyrazole derivatives: Synthesis, alkaline phosphatase, nucleotide pyrophosphatase/phosphodiesterase and nucleoside triphosphate diphosphohydrolase inhibition studies with potential anticancer profile.
Channar PA; Afzal S; Ejaz SA; Saeed A; Larik FA; Mahesar PA; Lecka J; Sévigny J; Erben MF; Iqbal J
Eur J Med Chem; 2018 Aug; 156():461-478. PubMed ID: 30015078
[TBL] [Abstract][Full Text] [Related]
19. Structure-activity relationship study of NPP1 inhibitors based on uracil-N1-(methoxy)ethyl-β-phosphate scaffold.
Nassir M; Pelletier J; Arad U; Arguin G; Khazanov N; Gendron FP; Sévigny J; Senderowitz H; Fischer B
Eur J Med Chem; 2019 Dec; 184():111754. PubMed ID: 31610377
[TBL] [Abstract][Full Text] [Related]
20. Adenine-(methoxy)-ethoxy-P
Nassir M; Mirza S; Arad U; Lee S; Rafehi M; Yaw Attah I; Renn C; Zimmermann H; Pelletier J; Sévigny J; Müller CE; Fischer B
Org Biomol Chem; 2019 Nov; 17(46):9913-9923. PubMed ID: 31720670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
